Life Sciences Archivi - Pagina 3 di 7

2 novembre 2023

3D Bioprinting – Industry Development and Forecast Report 2030

The 3D bioprinting market will power at a rate of 19.4% in the future, to reach USD 5,873 million by 2030. Living organs can be printed in 3D by layering living cells, which is the reason why bio engineering is progressively significant to human society.

With the growing requirement for bio-engineered organs, investigators have made key progressions in this tech.

Hence, the expansion of 3D biomaterials and bioprinters, their use in the pharma and cosmetics industries, and the surge in private and public financing for bioprinting research actions are persuading the industry positively.

Doctors make use of additive manufacturing for the creation of new bones and organs, and it is a major innovation in healthcare. Also, this allows the printing of prosthetic limbs for replacing missing limbs.

Additionally, as compared to the traditional process, which needs a long time and a donor, 3D bioprinting allows the transplantation to be done at a much faster pace.

The requirement for indispensable body parts for transplantation is enormously high globally. For making the things worse, there is an enormous gap amid the supply and requirement of tissues and organs. Numerous organs, for example the kidneys, lungs, heart, pancreas, liver, and intestines, are desired for transplantation.

Likewise, the requirement for heart valves, corneas, skin, blood vessels, and bones for transplantation is somewhat high. Rates of organ donation are still, while the requirement for tissues and organs is growing.

The inaccessibility of such parts for transplantation has brought about an increase in count of patients on the transplantation waiting list, a main anxiety for healthcare organization and providers.

Download free sample copy of this report: https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market/report-sample

North America held about 40% share in the recent past, because of the tech-progressions, growing R&D activities and improving healthcare infra. Other than that, the increasing expenditure on healthcare, growing elderly population, and growing prevalence of chronic ailments, is powering the requirement for this tech, particularly in the pharma sector.

APAC 3D bioprinting market will grow the fastest, chiefly due to the fact that its large base of consumers, increasing R&D in this field, and support of the government and tax breaks.

Researchers from China have brought about major progressions in this tech, for instance the liquid-inliquid printing process, in which liquid polymers are combined for forming a steady membrane.

They state that the subsequent liquid developments can hold their shape for about 240 hours, before the combining commences. They printed numerous difficult shapes with the use of this novel method, which has also opened the way for tissue printing from living cells.

The high requirement for tissues and organ transplants all over the world has a lot to do with the increasing demand for 3D bioprinting process.

1 novembre 2023

North America Is Dominating Medical Aesthetics Industry

The medical aesthetics market is projected to be worth USD 34,124.0 million by 2030, growing at a CAGR of 12.4%. This would be a result of the increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people.

Furthermore, the acceptance of non-invasive and minimally invasive aesthetic methods is increasing worldwide due to the loose facial skin, specifically around the jowls, cheeks, and eyes, and dry skin for others, which are some of the significant changes that typically happen when an individual ages. In addition, the need for aesthetic equipment is growing, because of the surging acceptance of cosmetic methods among common people, to look better.

North America held the largest revenue share in recent years and the continent is also projected to be in the leading position to reach USD 15 billion by 2030. This can be credited to innovation in cosmetic practices as a huge number of future key players and established players either have headquarters or have a significant existence in the region.

Get the sample copy of this report: https://www.psmarketresearch.com/market-analysis/medical-aesthetics-market/report-sample

Moreover, the growing investment in the healthcare sector, the governments’ supportive initiatives for inviting foreign investments, and the mounting R&D development via enhanced technologies are contributing to the growth of the regional market.

The APAC medical aesthetics market is projected to grow at a significant rate in the years to come. Developing countries in the region are showing a significant surge in the use of cosmetic treatments, mainly due to the reasons like increasing per capita income of middle-class people, the aging population, the growing awareness about skin problems, and the snowballing number of medical tourists in the region choosing for cosmetic treatments.

In recent years, the injectables category had the largest revenue share of over 40%, this can be ascribed to growing sales of injectables, including dermal fillers, botulinum toxin, and neurotoxins. In addition, the need for injectables is growing because of several factors like short procedure time, minimal scarring, instant result, cost-efficiency of the products, and minimally invasive.

The beauty clinics category holds the largest revenue share of over 50%, mainly because of the increasing per-capita of many countries, and also the snowballing number of beauty centers throughout the world. Such clinics come with several aesthetic treatments, including wrinkle treatment, body enhancement, augmentation, and scar removal. This is why the demand for dermal fillers and neurotoxins in beauty clinics and centers is increasing.

Hence, the Increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people are the major factors contributing to the growth of the medical aesthetics market.

30 ottobre 2023

Minimally Invasive Surgical Instruments Demand was Led by North America

As stated in one of its reports by P&S Intelligence, minimally invasive surgical instruments market is projected to touch USD 37,155.7 million by 2030, proceeding at a rate of 7.2% by the end of this decade.

Handheld instruments had the largest share of about 40% in 2022, and the situation will continue to be like this in the years to come.

This has a lot to do with the increasing acceptance of these instruments for a number of MIS surgeries, increasing acceptance of robot-assisted surgeries, and growing preference for such instruments by surgeons.

North America was the leader of the minimally invasive surgical instruments market, with a share of about 40% in 2022, and it will continue like this in the years to come.

This is due to the existence of organized healthcare systems, surge in the occurrence of diseases, for instance orthopedic and cardiac disorders, higher acceptance rate for cutting-edge devices, and shifting preference toward outpatient surgeries.

APAC will grow the fastest, powering at a rate of approximately 10% in the years to come. This is as a result of the growing cases of chronic ailments, rising elderly population, growing consciousness of people with regards to medical device outsourcing, trending medical tourism, and rise in healthcare spending.

The increasing investments in research and development in medical industry is directly proportional to the growing demand for minimally invasive surgical instruments all over the world.

27 ottobre 2023

North America is dominating Capnography Devices Industry

The global capnography devices market is experiencing growth and is projected to reach USD 736.6 million by 2030, according to P&S Intelligence. This growth can be ascribed to the rising occurrence of respiratory illnesses, rising elderly populace, technological improvements in capnography devices, and growing government initiatives, throughout the world.

In the coming few years, the multi-parameter capnography devices category is projected to experience the fastest development in the capnography devices market, based on product type. This can be primarily contributed to the fact that these devices can be combined into patient monitoring systems conveniently for the finding of numerous parameters of patients, and some of them can also be utilized as pulse oximeters.

In recent years, on the basis of technology, Side-stream-based capnography devices had the largest market share in the capnography devices market. This is mainly because of the fact that such devices offer adequate measurable bedside data regarding uneven alveolar emptying and ventilation–perfusion disparity, and this technology needs no standardization before use and has a tremendously short warm-up time enabling its use in emergency circumstances.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=capnography-devices-market

In recent years, the North American region dominated the industry, with the largest market share. This can be attributed to the high occurrence of respiratory medical situations, the existence of key industry players providing capnography devices, enhanced healthcare infrastructure, and high knowledge among healthcare professionals, in the continent.

Technological improvements in capnography have been the key boosting reason for the capnography devices industry, which comprise the combination of photo sensors and MCS in micro-stream capnography devices, and the combination of reduced main-stream multi-gas monitors.

Hence, the rising occurrence of respiratory illnesses, the rising elderly populace, technological improvements in capnography devices, and growing government initiatives, are the major factors propelling the capnography devices market.

11 ottobre 2023

Home-Use Insulin Delivery Devices Industry Was Dominated by North America

The home-use insulin delivery devices market will generate USD 19,087.6 million in 2030, progressing at a rate of 10.2% in the years to come, as stated by a market research report, published by P&S Intelligence.

The growing pervasiveness of diabetes, tech progressions, increasing aging population, and growing contact of the populace to main risk factors, for example an inactive lifestyle, obesity, and smoking, are main factors powering the industry.

The insulin pens category dominated the industry, on the basis of type. This is mostly credited to the growing incidence of diabetes, particularly in APAC countries, and tech expansions in insulin delivery pens.

Request for sample pages of this report: https://www.psmarketresearch.com/market-analysis/home-use-insulin-delivery-devices-market/report-sample

Moreover, the medical reimbursements provided in advanced nations are augmenting the growth of the market.

Reusable pens dominated the industry in the past, based on the type of insulin pen. This has a lot to do with the user-friendly design of these pens that supports in curtailing the dose errors.

The e-commerce category will grow the fastest in the future, on the basis of distribution channel. This is mostly credited to the development of e-pharmacies offering suitability to the customers. Moreover, the usage of e-prescriptions in hospitals is contributing to the growth of the category globally.

North America dominated the market in the past as a result of the increasing frequency of lifestyle ailments, such as obesity and diabetes, increasing consciousness about diabetes management, and growing healthcare spending.

Furthermore, insulin resistance and obesity have been measured independent risk factors for diabetes; therefore, the increasing obese populace supports the requirement for these devices.

The growing elderly population is a main factor stimulating the development of the home-use insulin delivery devices market. As per a report by the WHO, people are living longer, meaning that the average life expectancy of the populace has increased.

Furthermore, as per the World Population Ageing report in 2020, about 727 million individuals were aged 65 years and more all over the world, and this population will reach 1.5 billion by 2050.

Tech developments in insulin delivery devices are powering their growing acceptance. Insulin pumps, insulin pens and insulin inhalers have numerous compensations, for example precise dosage of insulin, thus helping uphold the usual level of the hormone in the body.

The use of insulin pens is a smaller amount of time consuming as opposed to syringes with vials. Additional advantages of insulin pens comprise superior patient suitability and minimum risk of imprecise dosage.

It is because of the increasing prevalence of diabetes, all over the world, the demand for home-use insulin delivery devices will continue to grow in the years to come.

28 settembre 2023

North America Is Dominating Hospital-Acquired Infection Control Industry

The global hospital-acquired infection control market will reach USD 34,909.7 million by 2030 developing at a CAGR of 1.6% during the projection period. This growth can be credited to the growing count of surgical conducts, rising knowledge regarding ecological and personal hygiene, and subsequent development in the occurrence of chronic illnesses.

In the past few years, an extreme surge in occurrences of cardiovascular diseases, neurological syndromes, and traumatic injuries, and the arrival of progressive medical technologies have been experienced. Because of such recurrent events, the industry for hospital-acquired infection control items is surging. For example, annually, the count of individuals going through neurological diseases or accidents is nearly 20 million and approximately 14 million of them need surgery.

The demand for hospital-acquired infection control items in ambulant surgical care centers is projected to advance at the highest CAGR, of 2%, during the forecast period, in the industry.

In recent years, the North American region dominated with the largest share, of 35%, in the hospital-acquired infection control market. This is credited to the rise in the elderly populace, the surge in the occurrence of chronic illnesses and hospital-acquired infections, and the existence of key industry players in the continent.

For example, in the U.S., the count of populaces aged more than 65 years is approximately 45 million and it is projected to reach more than 80 million by 2050. Furthermore, the occurrence of hospital-acquired infections in North America is very prominent. For instance, in American hospitals, the occurrence of HAIs is more than 1.5 million, and annually, 0.1 million demise happens because of this.

Hence, the growing count of surgical conducts, rising knowledge regarding ecological and personal hygiene, and subsequent development in the occurrence of chronic illnesses are the major factors propelling the industry.

18 settembre 2023

Microbiome Therapeutics Industry To Grow Fastest in the Asia-Pacific

The microbiome therapeutics market will power at a rate of 23.1% by the end of this decade, to reach USD 2,036.4 million by 2030.

The considerable role that the microbiome in gastrointestinal and non-gastrointestinal ailments makes it an alluring target for novel therapies. Furthermore, the industry is powered by the capability of digestive-related therapeutics for overcoming insufficiencies of conformist treatments, the likelihood of these therapeutics for meeting unmet needs of present therapeutic choices, growth in infection dimension, improved strategic activities, involvement of academic institutes, and documented businesses working in this field.

The FMT category led the industry in the past, and it will hold more than 84% share by 2030. This is because of the increase in the usage of fecal microbial transplants and the obtainability of FMT in the form of a capsule, which have increased the acceptability of patients for the treatments of C. difficile infection. Consequently, the growing prevalence of the illness will power the industry.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/microbiome-therapeutics-market/report-sample

APAC will grow the fastest with a rate of over 23%, by the end of this decade. The key factors powering the industry growth contain increasing healthcare spending, snowballing support of the government for fast-tracking clinical trials, and increasing consciousness about therapeutic goods.

Moreover, the growth of these treatments in the healthcare sector of the region is powerfully supported by tech developments in the infra and substantial investments.

It is due to the growth of strategic efforts for creating microbiome therapeutics, the demand for the same is on the rise, and it will continue to do the same in the years to come.

14 settembre 2023

Medical Ceramics Industry Analysis, Top Players and Forecast Report 2030

In 2022, the medical ceramics market had a total size of USD 2,543.2 million, and it is projected to hit USD 4,477.7 million by 2030, progressing at a rate of 7.3% from 2022 to 2030.

This development can be ascribed to the snowballing requirement for ceramics in several kinds of wound-curing applications and plastic surgeries, growing demand for implantable equipment for knee & hip replacement events, and increasing occurrence of bone syndromes among elderly people.

The growing rate of musculoskeletal conditions, including sports injuries, osteoporosis, rheumatoid arthritis, sarcopenia, fractures, and osteoarthritis, is boosting the requirement for knee and hip replacement operations worldwide.

According to reports by the WHO, musculoskeletal illnesses are the major causes of disability throughout the globe, with pain in the lower back considerably degrading the quality of life. In all, more than 1.71 billion people are suffering from musculoskeletal conditions globally.

Cosmetic dentistry has taken the procedures of dental well-being to new heights in terms of the aesthetics and the total well-being of individuals. A dental implant is a main component of cosmetic dentistry utilized in procedures, including placement of crowns, and dentures, filling of gaps and cracks, bridges, and reshaping of the teeth.

Cosmetic dentistry methods are progressively gaining traction among individuals of all age groups because of their rising knowledge of oral hygiene and the impact of strong and flawlessly aligned teeth in fuelling confidence.

In 2022, North America generated the largest revenue share, above 40%, in the international medical ceramics market. The regional industry is projected to continue with its dominance throughout the decade. This can be credited to the increasing size of dental implantation methods and the growing quantity of orthopedic surgical events in the continent.

Furthermore, the snowballing number of individuals with physical wounds and the fast acceptance of ceramics for the production of medical equipment are boosting regional growth.

In 2022, the bioinert category developed as the largest material category in the industry, had approximately 55% share, and was also projected to be on the leading spot throughout the decade. Bioinert ceramics contain aluminum and zirconia oxide.

This development in the need for such materials can be majorly credited to their exceptional chemical stability, which is commonly utilized to restore lapsing tissues or organs in patients’ bodies, armed with their robustness, corrosion resistance, and biocompatibility

Hence, the snowballing requirement for ceramics in several kinds of wound-curing applications and plastic surgeries, growing demand for implantable equipment for knee & hip replacement events, and increasing occurrence of bone syndromes among elderly people, are the major factors contributing in the growth of the market.

12 settembre 2023

North America Led the Healthcare Environmental Services Industry

The healthcare environmental services market will touch USD 25,008.7 million by 2030, growing at a rate of 8% during 2022–2030, as stated by a market professional at P&S Intelligence.

The industry growth is credited to the fact that regulatory agencies and governments are proposing strict regulations for controlling infections.

Furthermore, with a surge in the communicable ailment incidence, hygiene and infection control processes are getting more attention from healthcare facilities also.

Fundamentally, the increasing spending on the healthcare industry, growing hospital count, and large pool of patients are responsible for the growth of the industry.

Janitorial/core cleaning led the industry, with a share of about 60%, in 2022, and this scenario will continue in the years to come.

North America will continue dominating the industry, with a share of about 45% in 2030. This has a lot to do with the presence of the key players, cutting-edge healthcare ecosystem, beneficial compensation policies, and growing focus on improving the patient care standard.

Besides, many tech enhancements take place in the medical industry of North America on a yearly basis, powering the industry.

Europe will have a significant share as well in the healthcare environmental services market, due to the growing geriatric population in the region.

According to a study, 20.8% of the citizens of the European Union were aged 65 or more in 2021.

Older individuals are more vulnerable to chronic along with catching a number of infections, so there is a need of hospitalization and surgeries for them, this will have a positive effect on the growth of the industry in the region.

With the rise in the incidence of infectious disease in the world, the graph of the demand for healthcare environmental services will see an upward shift in the years to come.

7 settembre 2023

Behavioral Health Software Industry Had a Major Share in Subscription Category

The behavioral health software market will power at a compound annual growth rate of 16.10% in the years to come, reaching at a value of USD 9,346 million by 2030.

The industry growth is driven by the increasing requirement for mental wellbeing software, obtainability of government subsidy, and initiatives to power the acceptance of EHRs in psychiatric hospitals. Essentially, the incessant necessity for solutions to advance mental health is the main element powering the expansion of the industry.

The services offered under the behavioral health umbrella comprise those for mental health, alcohol and drug misuse, anxiety, depression, post-traumatic stress ailment, schizophrenia, and eating ailments.

The subscription category accounted for major share in 2022 in the behavioral health software market, and it will power at a rate of about 17% in the years to come. Contrary to large medicinal offices or hospitals, utmost small mental healthcare providers do not have sufficient to send on solutions centered on cutting-edge technologies.

North America dominated the industry with a share of around 42%, in 2022, and it will continue dominating in the years to come. The large share of the U.S. in the region will be because in the number of people needing these services for freedom from mental ailments, surge in the subsidy by the government for their provisioning, and application of numerous behavioral health reforms. Moreover, the easy obtainability of repayment for telepsychiatry services and increasing knowledge of mental health software make the industry a promising industry.

It is due to the increasing occurrence of depression, anxiety, and PSTD, the demand for behavioral health software will continue to grow in the years to come.